Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01344356 · ClinicalTrials.gov registry record · Phase 4
Stereotactic Body Radiotherapy for Head and Neck Tumors
A Phase 4 study, sponsored by Mercy Research.
- Completed
- Registry status
- Phase 4
- Development phase
- 19
- Enrollment target
NCT01344356: Completed Phase 4 study, sponsored by Mercy Research.
NCT01344356 is a Phase 4 study that has completed, run by Mercy Research. The registered enrollment target is 19 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01344356, a Phase 4 study, has completed, sponsored by Mercy Research.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 19 participants
- Enrollment target
Study Summary
This study will evaluate the local control rates as well as acute and late toxicity rates of stereotactic body radiotherapy (SBRT) for the treatment of benign and malignant head and neck tumors.
Primary Outcome
Complete or partial tumor response or stable disease
Interventions
- RADIATION stereotactic body radiotherapy
- RADIATION Stereotactic body radiotherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2008-07 |
| Est. Completion | 2018-05 |
| Phase | Phase 4 |
What the finished NCT01344356 record still lists
NCT01344356 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which stereotactic body radiotherapy is the first listed.
NCT01344356 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01344356 about?
NCT01344356 is a clinical study titled "Stereotactic Body Radiotherapy for Head and Neck Tumors". This study will evaluate the local control rates as well as acute and late toxicity rates of stereotactic body radiotherapy (SBRT) for the treatment of benign and malignant head and neck tumors.
What is the current status of trial NCT01344356?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 19 participants. The study started on 2008-07. Estimated completion is 2018-05.
What interventions are being tested in trial NCT01344356?
The interventions under investigation include: stereotactic body radiotherapy (RADIATION), Stereotactic body radiotherapy (RADIATION).
Who is sponsoring clinical trial NCT01344356?
This trial is sponsored by Mercy Research, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01344356's enrollment target sits among peer trials
19 1834th of 2000 higher than 159 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia